IMA - Ikena Oncology, Inc.
5.84
-0.200 -3.425%
Share volume: 5,223
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$6.04
-0.20
-0.03%
Summary score
37%
Profitability
43%
Dept financing
20%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.1%
Return on assets
-8.63%
Return on sales
-1413.19%
Return on invested capital
653.36%
Total debt ratio
12.26%
Debt ratio change over timeo
-1.01%
Current Ratio
11.66%
Quick Ratio
9.47%
Cash Position Ratio
7.75%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-8.44%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
10.46%
Debt ratio change over timeo
0%
Current Ratio
12.97%
Quick Ratio
0%
Cash Position Ratio
6.26%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-15.39%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
13.08%
Debt ratio change over time
0%
Current Ratio
13.24%
Quick Ratio
0%
Cash Position Ratio
9.26%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-98.5%
Return on assets
-99.08%
Return on sales
-471.3%
Return on invested capital
10.77%
Total debt ratio
-101.2%
Debt ratio change over time
-1.01%
Current Ratio
-1.54%
Quick Ratio
-1.67%
Cash Position Ratio
-1.59%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IMA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -9.1% | 28.34% | 5.51% | 6.15% |
| Return on assets | -8.63% | 3.06% | 3.18% | 2.21% |
| Return on sales | -1413.19% | 28.09% | 27.06% | 23.01% |
| Return on invested capital | 653.36% | 6.42% | 3.22% | 6.7% |
| Profitability | 25% | 74% | 54% | 44% |
| Total debt ratio | 12.26% | 93.19% | 66.22% | 44.66% |
| Debt ratio change over time | -1.01% | 12.76% | 169.64% | 13.01% |
| Dept financing | 3% | 27% | 43% | 14% |
| Current Ratio | 12.97% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 6.26% | 0.43% | 0.63% | 0.74% |
| Liquididy | 75% | 10% | 8% | 11% |
| Short-term ratios | IMA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -8.44% | 3.09% | 4.74% | 1.98% |
| Return on sales | 0% | 23.81% | 35.93% | 22.2% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 33% | 50% | 26% |
| Total debt ratio | 10.46% | 91.88% | 65.29% | 38.81% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 25% | 18% | 11% |
| Current Ratio | 12.97% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 6.26% | 0.43% | 0.63% | 0.74% |
| Liquididy | 50% | 21% | 28% | 32% |